Journal of Cancer Treatment and Research

Volume 3, Issue 2, March 2015

  • Endometrial Curettage When and for Who

    Aslıhan Duman, Ferah Tuncel Daloğlu, Yeliz Arman Karakaya, Aysun Aras

    Issue: Volume 3, Issue 2, March 2015
    Pages: 17-21
    Received: 12 February 2015
    Accepted: 27 February 2015
    Published: 9 March 2015
    Abstract: In this study, the histopathological diagnoses pertaining to curettage material and the clinical necessity and results of endometrial curettagein age groups of patients in our region who had curettage due to abnormal uterine bleeding were studied. Thehistopathological diagnoses of patients with the above-mentioned criteria were scanned, excluding t... Show More
  • A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5

    Aruba Cham, Kai Cham, Tania Chase, Bill Cham

    Issue: Volume 3, Issue 2, March 2015
    Pages: 22-27
    Received: 26 February 2015
    Accepted: 19 March 2015
    Published: 24 March 2015
    Abstract: New approaches to curb developmental and end-stage production expenses, whilst generating a safe and effective treatment for cancer, resulting in lower cost for the patient and healthcare system, are warranted. A bioassay-guided fractionation of a Solanum plant, S. sodomaeum, to a standardized extract can be classified as a new drug. It is shown th... Show More